desipramine has been researched along with Invasiveness, Neoplasm in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perry, DM | 1 |
| Newcomb, B | 1 |
| Adada, M | 1 |
| Wu, BX | 1 |
| Roddy, P | 1 |
| Kitatani, K | 1 |
| Siskind, L | 1 |
| Obeid, LM | 1 |
| Hannun, YA | 1 |
1 other study available for desipramine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Defining a role for acid sphingomyelinase in the p38/interleukin-6 pathway.
Topics: Cell Line, Tumor; Cells, Cultured; Desipramine; Enzyme Inhibitors; Gene Knockdown Techniques; HeLa C | 2014 |